United States · FDA National Drug Code directory
ivabradine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1863_b83cc3b5-db55-4fc0-a89d-2cae17fcd445
- Product NDC
- 70771-1863
- Form
- TABLET
- Composition / generic term
- ivabradine
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240702
- Source listing expiry
- 20261231
Source-listed ingredients
- IVABRADINE HYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 BOTTLE (70771-1863-6) · 70771-1863-6
- 180 TABLET in 1 BOTTLE (70771-1863-8) · 70771-1863-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →